It wasn't so long ago when Novo Nordisk (NYSE: NVO) and Eli Lilly (NYSE: LLY) stocks were flying high thanks to their hotly popular weight loss drugs (Wegovy/Ozempic for Novo Nordisk and ...
SolarWinds Q1 revenue up 4% to $193.31M, topping forecasts; adjusted EPS of $0.29 beats $0.22 estimate. Subscription revenue jumps 26.5% to $68.76M; adjusted EBITDA margin rises sharply by 600 bps to ...
Adobe nearly bought Figma for $20 billion in 2022, but antitrust regulators scuttled the deal. Today, Figma has a market cap ...
The study did not meet its primary endpoint of efficacy against acute gastroenteritis events due to GI.1 or GII.4 norovirus genotypes. No clinical benefit was observed across secondary endpoints.
Gyan Developers Share: compare Gyan Developers with up to two competing stocks only on Moneycontrol. Use our stock comparison tool to check price, market cap, returns & more ...
BANGKOK, April 25 (Reuters) - Thailand's benchmark stock index was down 0.09 percent at 1,104.27 near the midsession break on Monday in turnover of 10.5 billion Thai baht ($351 million). Low-end ...
Hosted on MSN
Why Weight-Loss Developer Stocks Tumbled on Tuesday
Makers of weight-loss drugs, the hottest segment of the pharmaceutical market just now, weren't looking so hot on the stock exchange Tuesday. A pronouncement from President Trump about the category ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback